Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer

NCT00070057 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Stage I Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

DRUG: celecoxib
PROCEDURE: therapeutic conventional surgery
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)